Skip to main content
General Surgery In-depth Review Seminar Main banner
Back
Evaluation/Tests

Malignant Melanoma--Where are we in 2021?

Wednesday, April 28, 2021
12:40 PM – 1:10 PM ET
CME Credit: 0.50

    Non-Member Speaker(s)

  • Adam Berger, MD FACS

    Chief of Melanoma and Sarcoma Surgical Oncology
    Rutgers Cancer Institute of New Jersey
    Robert Wood Johnson Medical School

Learning Objectives:

  • Upon completion, participants will be able to understand the appropriate margins to remove when performing wide excision of melanoma.
  • Upon completion, participants will be able to understand the available treatment options for patients with Stage III and IV melanoma.
  • Upon completion, participants will be able to understand the indications for performing a sentinel lymph node biopsy and its importance.
  • Upon completion, participants will be able to understand the preferred methods of biopsying pigmented lesions